BIT Computer Valuation
Is A032850 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A032850 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: A032850 (₩5240) is trading above our estimate of fair value (₩3573.16)
Significantly Below Fair Value: A032850 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A032850?
Other financial metrics that can be useful for relative valuation.
What is A032850's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₩84.47b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.7x |
Enterprise Value/EBITDA | 7.5x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does A032850's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 43.7x | ||
A099750 ezCaretech | 37.9x | n/a | ₩105.6b |
A071200 INFINITT Healthcare | 4x | n/a | ₩108.4b |
A142280 Green Cross Medical Science | 75.6x | n/a | ₩88.9b |
A450330 HASS | 57.5x | n/a | ₩97.0b |
A032850 BIT Computer | 13.6x | n/a | ₩84.5b |
Price-To-Earnings vs Peers: A032850 is good value based on its Price-To-Earnings Ratio (13.6x) compared to the peer average (43.7x).
Price to Earnings Ratio vs Industry
How does A032850's PE Ratio compare vs other companies in the Asian Healthcare Services Industry?
Price-To-Earnings vs Industry: A032850 is good value based on its Price-To-Earnings Ratio (13.6x) compared to the Asian Healthcare Services industry average (26.4x).
Price to Earnings Ratio vs Fair Ratio
What is A032850's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 13.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate A032850's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.